Smithers Pharmaceutical Development Services to Attend AAPS National Biotechnology Conference 2026

Smithers Pharmaceutical Development Services will participate in the AAPS National Biotechnology Conference, taking place May 11–14, 2026, at the Sheraton San Diego Resort in San Diego. The event convenes biotechnology and pharmaceutical professionals focused on advancing biologics development, manufacturing, and regulatory strategy.

Executive Access at Booth 304

Smithers will host meetings at booth 304 with senior leadership in attendance. Christina Satterwhite, President; Connie Scott, Senior Director, Business Development; Emma Zhao, Senior Project Manager; Ivan Ivanov, Project Manager; and Irakli Sulaberidze, Associate Project Manager will represent Smithers Pharmaceutical Development Services throughout the conference.

Direct access to executive leadership enables efficient, decision-oriented discussions. Sponsors can address program risks, timelines, and data requirements without delay. Conversations are structured to align with defined development goals and regulatory expectations.

Focus on Biologics Development and Analytical Strategy

AAPS NBC centers on biologics, including monoclonal antibodies, cell and gene therapies, and advanced modalities. Smithers Pharmaceutical Development Services supports these programs with integrated analytical services, formulation development, stability studies, and method validation.

At the conference, Smithers will engage sponsors on topics that affect development outcomes. These include comparability strategies, characterization of complex biologics, impurity profiling, and stability-indicating methods. Emphasis is placed on generating defensible data packages that support IND, BLA, and lifecycle management.

Regulatory Alignment and Program Execution

Regulatory expectations for biologics continue to evolve. Smithers Pharmaceutical Development Services addresses this through data integrity, method robustness, and documentation that withstands agency review.

Meetings at booth 304 will focus on aligning analytical strategies with regulatory pathways. Discussions will include phase-appropriate validation, specification setting, and risk-based approaches to method development. The objective is to reduce rework and support timely submissions.

Integrated Support Across Development Stages

Smithers Pharmaceutical Development Services delivers support from early-phase development through commercial readiness. Services are structured to maintain continuity across stages, with clear data transfer and method lifecycle management.

Sponsors attending AAPS NBC can review current programs, assess gaps, and define next steps with Smithers leadership. Engagements are structured to move from assessment to execution with defined timelines and deliverables.

Schedule a Meeting with Smithers Pharmaceutical Development Services

Smithers Pharmaceutical Development Services invites conference attendees to meet at booth 304 during AAPS NBC 2026. Engage directly with executive leadership to address program challenges, refine analytical strategies, and define a clear path forward.

Contact Smithers Pharmaceutical Development Services to schedule a meeting in advance. Early coordination ensures dedicated time with the appropriate subject matter experts and supports focused, outcome-driven discussions.